Osurnia 1 mg (Betamethasone Acetate GEL) 1 MG

Osurnia 1 mg is a betamethasone acetate gel designed for otic (ear) use. This medication combines anti-inflammatory and antimicrobial properties to support ear health. Ideal for managing ear conditions requiring localized treatment.

Strength

1 MG

Manufacturer / TM Owner

DECHRA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Osurnia 1 mg gel is primarily used for managing ear inflammation and infections. It is often recommended for conditions requiring localized anti-inflammatory and antimicrobial action. This gel is applied directly to the ear canal to help alleviate symptoms associated with ear disorders.

Side Effects

Osurnia 1 mg gel may reduce inflammation and combat microbial activity in the ear. Users might experience relief from discomfort and swelling. As with any medication, individual responses can vary, and it's important to follow healthcare provider instructions.

Precautions & Warnings

Osurnia 1 mg gel should be used as directed to avoid potential irritation. Keep the gel away from eyes and mucous membranes. Ensure proper hygiene when applying the gel to prevent contamination. Consult a healthcare provider before use if you have known allergies or sensitivities.

Avoid Interactions

Osurnia 1 mg gel may interact with other otic medications. Avoid using it with other ear treatments unless advised by a healthcare provider. Inform your healthcare provider about all medications you are taking to prevent potential interactions.

Frequently Asked Questions

Osurnia 1 mg gel is used to manage ear inflammation and infections. It combines anti-inflammatory and antimicrobial properties for localized treatment.

Osurnia 1 mg gel is applied directly into the ear canal. Follow the instructions provided by your healthcare provider for proper administration.

Common side effects may include irritation or discomfort in the ear. Individual responses can vary, and it's important to monitor for any adverse reactions.

Osurnia 1 mg gel should not be used with other ear treatments unless advised by a healthcare provider to avoid potential interactions.

The safety of Osurnia 1 mg gel for long-term use should be discussed with a healthcare provider. Follow their guidance for prolonged treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.